Privi Speciality Chemicals Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Privi Speciality Chemicals wird ein Gewinn- und Umsatzwachstum von 22% bzw. 13% pro Jahr prognostiziert, während der Gewinn pro Aktie um 21.5% pro Jahr wachsen soll.
Wichtige Informationen
22.0%
Wachstumsrate der Gewinne
21.5%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 20.7% |
Wachstumsrate der Einnahmen | 12.9% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 05 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump
Jun 25Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt
Jun 04What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You
Apr 30Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Sep 05These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively
Mar 10Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Sep 21Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet
Jun 21Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden
Feb 15Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?
May 24Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares
Feb 26Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return
Feb 24Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Jan 31What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend
Jan 16Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Jan 03Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?
Dec 21Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares
Dec 08If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns
Nov 25Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 12Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?
Oct 21Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why
Oct 12Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?
Sep 27A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price
Sep 14The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares
Aug 28Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?
Aug 18Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Aug 03Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?
Jul 19Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?
Jul 07Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?
Jun 25Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2026 | 22,583 | 1,751 | 2,225 | N/A | 1 |
3/31/2025 | 19,669 | 1,308 | 2,532 | N/A | 1 |
6/30/2024 | 18,075 | 1,217 | N/A | N/A | N/A |
3/31/2024 | 17,522 | 949 | 2,040 | 3,545 | N/A |
12/31/2023 | 16,666 | 502 | N/A | N/A | N/A |
9/30/2023 | 16,826 | 271 | 1,771 | 3,227 | N/A |
6/30/2023 | 16,277 | 45 | N/A | N/A | N/A |
3/31/2023 | 16,078 | 222 | -909 | 488 | N/A |
12/31/2022 | 15,860 | 658 | N/A | N/A | N/A |
9/30/2022 | 15,607 | 851 | -3,863 | -1,785 | N/A |
6/30/2022 | 14,602 | 905 | N/A | N/A | N/A |
3/31/2022 | 14,037 | 974 | -3,039 | 47 | N/A |
12/31/2021 | 13,800 | 1,273 | N/A | N/A | N/A |
9/30/2021 | 13,125 | 1,212 | -2,421 | 949 | N/A |
6/30/2021 | 13,196 | 1,249 | N/A | N/A | N/A |
3/31/2021 | 12,766 | 1,169 | -935 | 1,493 | N/A |
12/31/2020 | 15,391 | 1,224 | N/A | N/A | N/A |
9/30/2020 | 15,218 | 1,350 | 918 | 3,042 | N/A |
6/30/2020 | 15,027 | 1,607 | N/A | N/A | N/A |
3/31/2020 | 13,241 | 1,460 | 357 | 2,161 | N/A |
12/31/2019 | 16,737 | 1,819 | N/A | N/A | N/A |
9/30/2019 | 16,618 | 2,135 | -317 | 1,770 | N/A |
6/30/2019 | 15,543 | 1,655 | N/A | N/A | N/A |
3/31/2019 | 13,410 | 942 | -1,482 | 210 | N/A |
12/31/2018 | 12,149 | 682 | N/A | N/A | N/A |
9/30/2018 | 11,089 | 86 | N/A | N/A | N/A |
6/30/2018 | 10,493 | 103 | N/A | N/A | N/A |
3/31/2018 | 10,243 | 534 | N/A | 1,066 | N/A |
12/31/2017 | 9,328 | 293 | N/A | N/A | N/A |
9/30/2017 | 8,319 | 262 | N/A | N/A | N/A |
6/30/2017 | 7,659 | 257 | N/A | N/A | N/A |
3/31/2017 | 5,973 | 271 | N/A | 166 | N/A |
12/31/2016 | 1,727 | 128 | N/A | N/A | N/A |
9/30/2016 | 1,686 | 138 | N/A | N/A | N/A |
6/30/2016 | 1,590 | 141 | N/A | N/A | N/A |
3/31/2016 | 1,517 | 106 | N/A | 161 | N/A |
12/31/2015 | 1,468 | 86 | N/A | N/A | N/A |
9/30/2015 | 1,452 | 79 | N/A | N/A | N/A |
6/30/2015 | 1,458 | 91 | N/A | N/A | N/A |
3/31/2015 | 1,506 | 137 | N/A | 321 | N/A |
12/31/2014 | 1,583 | 171 | N/A | N/A | N/A |
9/30/2014 | 1,605 | 196 | N/A | N/A | N/A |
6/30/2014 | 1,639 | 211 | N/A | N/A | N/A |
3/31/2014 | 1,518 | 187 | N/A | 122 | N/A |
12/31/2013 | 1,366 | 134 | N/A | N/A | N/A |
9/30/2013 | 1,251 | 106 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: PRIVISCLDas prognostizierte Gewinnwachstum (30% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: PRIVISCLDie Erträge des Unternehmens (30% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (16% pro Jahr).
Hohe Wachstumserträge: PRIVISCLEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: PRIVISCLDie Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.4% pro Jahr).
Hohe Wachstumseinnahmen: PRIVISCLDie Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von PRIVISCL in 3 Jahren voraussichtlich hoch sein wird